Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women.

MLA

Yoshida, Yilin, et al. “Menopausal Hormone Therapy and Risk of Cardiovascular Events in Women with Prediabetes or Type 2 Diabetes: A Pooled Analysis of 2917 Postmenopausal Women.” Atherosclerosis (00219150), vol. 344, Mar. 2022, pp. 13–19. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2022.01.016.

APA

Yoshida, Y., Chen, Z., Baudier, R. L., Krousel-Wood, M., Anderson, A. H., Fonseca, V. A., & Mauvais-Jarvis, F. (2022). Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women. Atherosclerosis (00219150), 344, 13–19. https://doi.org/10.1016/j.atherosclerosis.2022.01.016

Chicago

Yoshida, Yilin, Zhipeng Chen, Robin L. Baudier, Marie Krousel-Wood, Amanda H. Anderson, Vivian A. Fonseca, and Franck Mauvais-Jarvis. 2022. “Menopausal Hormone Therapy and Risk of Cardiovascular Events in Women with Prediabetes or Type 2 Diabetes: A Pooled Analysis of 2917 Postmenopausal Women.” Atherosclerosis (00219150) 344 (March): 13–19. doi:10.1016/j.atherosclerosis.2022.01.016.